Rimegepant for the acute treatment of migraine in adults from China

被引：0
|
作者：
Yu, S. [1 ]
Guo, A. [2 ]
Zhang, M. [1 ]
Wang, Z. [3 ]
Liu, J. [4 ]
Tan, G. [5 ]
Yang, Q. [6 ]
Liu, Y. [7 ]
Zhao, Q. [8 ]
Lu, Z. [9 ]
Atkinson, J. [10 ]
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[2] Yanan Univ, Xianyang Hosp, Xianyang, Peoples R China
[3] Changsha Cent Hosp, Changsha, Peoples R China
[4] Wuhan Third Hosp, Wuhan, Peoples R China
[5] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China
[6] Shanxi Prov Hosp, Xian, Peoples R China
[7] Pfizer Inc, Beijing, Peoples R China
[8] Pfizer Inc, Chengdu, Peoples R China
[9] Pfizer China Res & Dev Ltd, Shanghai, Peoples R China
[10] Pfizer LTD, Tadworth, England
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P030
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine (vol 37, pg 255, 2023)
    Blair, Hannah A. A.
    CNS DRUGS, 2023, 37 (07) : 661 - 661
  • [32] Evaluation of rimegepant utilization patterns for acute and preventive treatment of migraine in a commercially insured population
    Brown, J.
    Jenkins, A.
    Blakeman, Hygge K.
    Lipton, R.
    HEADACHE, 2023, 63 : 54 - 55
  • [33] Evaluation of rimegepant utilization patterns for acute and preventive treatment of migraine in a commercially insured population
    Ailani, J.
    Brown, J.
    Jenkins, A.
    Blakeman, K. Hygge
    Lewis, M.
    Cirillo, J.
    Lipton, R. B.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [34] Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine in Black and African American Adults: Results From 3 Randomized, Placebo-Controlled Clinical Trials
    Charleston, L.
    Armand, C.
    Helveston, W.
    Monteith, T.
    O'Brien, H.
    Croop, R.
    Thiry, A.
    Morris, B.
    Forshaw, M.
    Abbott, C.
    HEADACHE, 2023, 63 : 131 - 132
  • [35] Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine in Black and African American Adults: Results From 3 Randomized, Placebo-Controlled Clinical Trials
    Charleston, Larry
    Armand, Cynthia
    Helveston, Wendell
    Monteith, Teshamae
    O'Brien, Hope
    Croop, Robert
    Thiry, Alexandra
    Morris, Beth
    Forshaw, Micaela
    Abbott, Chandra
    NEUROLOGY, 2023, 100 (17)
  • [36] Patterns of medication utilization and migraine frequency in adults using rimegepant for both preventive and acute treatment for migraine: Results from a 52-week, open-label extension study
    Hutchinson, S.
    Goodrich, R.
    HEADACHE, 2022, 62 (07): : 926 - 927
  • [37] Patterns of Medication Utilization and Migraine Frequency in Adults Using Rimegepant for Both Preventive and Acute Treatment for Migraine: Results From a 52-Week, Open-Label Extension Study
    Hutchinson, Susan
    Mullin, Kathleen
    Pavlovic, Jelena
    Lipton, Richard
    Jensen, Christopher
    Thiry, Alexandra
    Kamen, Lisa
    Croop, Robert
    NEUROLOGY, 2023, 100 (17)
  • [38] Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial
    Yu, Shengyuan
    Guo, Aihong
    Wang, Zhen
    Liu, Jianguang
    Tan, Ge
    Yang, Qian
    Zhang, Mingjie
    Yibulaiyin, Hasiyeti
    Chen, Huisheng
    Zhang, Yongbo
    Croop, Robert
    Sun, Yanhui
    Liu, Yu
    Zhao, Qian
    Lu, Zhihong
    JOURNAL OF HEADACHE AND PAIN, 2024, 25 (01):
  • [39] Rimegepant for the Acute Treatment of Migraine in Patients with a History of Triptan Treatment Failure: Pooled Results From 3 Phase 3 Clinical Trials
    Jensen, Christopher
    Lipton, Richard
    Blumenfeld, Andrew
    Croop, Robert
    Thiry, Alexandra
    L'Italien, Gilbert
    Morris, Beth
    Coric, Vlad
    Goadsby, Peter
    NEUROLOGY, 2021, 96 (15)
  • [40] Long-Term Safety of Rimegepant 75 mg for the Acute Treatment of Migraine (Study 201)
    Croop, Robert
    Berman, Gary
    Kudrow, David
    Mullin, Kathleen
    Stock, Elyse
    Thiry, Alexandra
    Conway, Charles
    Jensen, Christopher
    Lovegren, Meghan
    Coric, Vladimir
    Lipton, Richard
    NEUROLOGY, 2020, 94 (15)
12345